1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Pituitary ACTH Hypersecretion (Cushing's Disease) Global Clinical Trials Review, H1, 2014

Pituitary ACTH Hypersecretion (Cushing's Disease) Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Pituitary ACTH Hypersecretion (Cushing's Disease) Global Clinical Trials Review, H1, 2014" provides data on the Pituitary ACTH Hypersecretion (Cushing’s Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pituitary ACTH Hypersecretion (Cushing’s Disease). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pituitary ACTH Hypersecretion (Cushing’s Disease). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Pituitary ACTH Hypersecretion (Cushing's Disease) Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Pituitary ACTH Hypersecretion (Cushing's Disease) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Pituitary ACTH Hypersecretion (Cushing's Disease) to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Pituitary ACTH Hypersecretion (Cushing's Disease) to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Pituitary ACTH Hypersecretion (Cushing's Disease) 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Novartis AG 30
Clinical Trial Overview of Novartis AG 30
Corcept Therapeutics Incorporated 31
Clinical Trial Overview of Corcept Therapeutics Incorporated 31
Isis Pharmaceuticals, Inc. 32
Clinical Trial Overview of Isis Pharmaceuticals, Inc. 32
Laboratoires Pierre Fabre SA 33
Clinical Trial Overview of Laboratoires Pierre Fabre SA 33
Cortendo Invest AB 34
Clinical Trial Overview of Cortendo Invest AB 34
Clinical Trial Overview of Top Institutes / Government 35
Eunice Kennedy Shriver National Institute of Child Health and Human Development 35
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 35
National Center for Research Resources 36
Clinical Trial Overview of National Center for Research Resources 36
University of Wurzburg 37
Clinical Trial Overview of University of Wurzburg 37
UCLA's Jonsson Comprehensive Cancer Center 38
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center 38
Erasmus MC 39
Clinical Trial Overview of Erasmus MC 39
Massachusetts General Hospital 40
Clinical Trial Overview of Massachusetts General Hospital 40
Assistance Publique - Hopitaux de Paris 41
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 41
Hiroshima University Hospital 42
Clinical Trial Overview of Hiroshima University Hospital 42
Universita di Padova 43
Clinical Trial Overview of Universita di Padova 43
Samsung Medical Center 44
Clinical Trial Overview of Samsung Medical Center 44
Five Key Clinical Profiles 45
Appendix 129
Abbreviations 129
Definitions 129
Research Methodology 130
Secondary Research 130
About GlobalData 131
Contact Us 131
Disclaimer 131
Source 131

List of Tables
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics, Global, Clinical Trials by Region, 2014* 7
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Pituitary ACTH Hypersecretion (Cushing's Disease) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Pituitary ACTH Hypersecretion (Cushing's Disease) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 30
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Corcept Therapeutics Incorporated, 2014* 31
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Isis Pharmaceuticals, Inc., 2014* 32
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Pierre Fabre SA, 2014* 33
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cortendo Invest AB, 2014* 34
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014* 35
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 36
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wurzburg, 2014* 37
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2014* 38
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014* 39
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 40
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 41
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hiroshima University Hospital, 2014* 42
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Universita di Padova, 2014* 43
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014* 44

List of Figures
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Pituitary ACTH Hypersecretion (Cushing's Disease) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Pituitary ACTH Hypersecretion (Cushing's Disease) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 130

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.